Action 002589 REALCAN PHARMACEUTICAL GROUP CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Realcan Pharmaceutical Group Co., Ltd.

Actions

002589

CNE1000013X5

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 30/04/2024 		Varia. 5j. Varia. 1 janv.
2,68 CNY -.--% Graphique intraday de Realcan Pharmaceutical Group Co., Ltd. +11,67% -18,04%
29/04 Realcan Pharmaceutical Group Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
2023 Realcan Pharmaceutical Group Co. annonce ses résultats pour les neuf mois se terminant le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Realcan Pharmaceutical Group Co., Ltd. Proposes the Profit Distribution for 2023
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) added to S&P Global BMI Index
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Realcan Pharmaceutical Group Co., Ltd. Approves the Executive Appointments
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shanghai Pharmaceutical Co., Ltd. entered into an agreement to acquire 51% stake in Hunan Runji Pharmaceutical Co., Ltd. from Realcan Pharmaceutical Group Co., Ltd. for CNY 149 million
Realcan Pharmaceutical Group Co., Ltd. agreed to acquire 9.6409% of Shandong Lekang Jinyue Industrial Co., Ltd. from Yantai Chenghou Investment Co., Ltd for CNY 84.84 million.
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Realcan Pharmaceutical Group Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 22, 2022
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) dropped from S&P Global BMI Index
Realcan Pharmaceutical Group Co., Ltd. Approves Cash Dividend for the Year 2021
Realcan Pharmaceutical Group Co., Ltd. Announces Profit Distribution Proposal for 2021
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Realcan Pharmaceutical Group Co., Ltd. agreed to acquire a 38.39992% stake in Tianjin Guohui Big Health Technology Co., Ltd. from Yantai Huishuo Enterprise Management Partnership Enterprise for approximately CNY 230 million.
Realcan Pharmaceutical Group Co., Ltd. acquired Health Technology for approximately CNY 230 million.
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) dropped from FTSE All-World Index
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002589
  4. Actualités Realcan Pharmaceutical Group Co., Ltd.
  5. Autres langues